In Vitro Diagnostics: Technologies and Global Market report

1
In Vitro Diagnostics Technologies Industry
2015
2
Summary
The global market for in vitro diagnostics (IVD)
products was totaled at 57.3 billion in 2014. It
is expected to grow from 60.3 billion in 2015 to
81.1 billion by 2020 at a compound annual growth
rate (CAGR) of 6.1 from 2015 to 2020. This
report provides -An overview of the global
markets and related technologies for in vitro
diagnostics -Analyses of global market trends,
with data from 2014, estimates for 2015, and
projections of compound annual growth rates
(CAGRs) through 2020
3
-Detailed coverage of application areas, end
users, and factors influencing and inhibiting
demand for IVD Information about IVD products
including reagents, instruments, and data
management softwares and services -A look at how
the rise in the number of diseases like
respiratory infections, hospital acquired
infections (HAI), and sexually transmitted
diseases are creating a constant need for
infectious disease testing both in hospitals and
laboratories -Segmentation into immunochemistry,
clinical chemistry, SMBG, POC, MDx, hematology,
microbiology, hemostasis and tissue
diagnostics -Application analysis Diabetes,
infectious, oncology, cardiology, neurology and
others. -Profiles of major players in the
industry
4

STUDY GOALS AND OBJECTIVES This report offers a
comprehensive analysis of the global in-vitro
diagnostic market, along with an in-depth study
of the various IVD segments (clinical chemistry,
immunoassays, point-of-care diagnostics,
molecular diagnostics, hematology, microbiology
and tissue diagnostics) products (instruments,
reagents and accessory products) end-user groups
(central labs, critical care, OTC/self-testing
and academia) and the regional markets of North
America, Europe, Asia and LAAM (Latin
America/Africa/Middle East). This report
provides a complete review and analysis of the
current trends in the IVD markets, along with
industry growth drivers and restraints. Revenues
are broken down by regions, segments, products
and end users, and sales figures have been
estimated for the five-year period from 2015
through 2020 in constant U.S. dollars.
5

REASONS FOR DOING THIS STUDY In vitro diagnostic
tests performed on biological samples, such as
blood, urine, saliva, spinal fluid and DNA, are a
key component of health care delivery. The
information provided by IVD tests enable medical
care providers to manage several diseases through
timely prevention, diagnosis and decision making,
and by administering patient-specific treatment
modalities. Due to recent rapid technological
advances and automation, the range and complexity
of diagnostic tests have overwhelmingly
increased. This has made lab tests much easier to
use and less error prone, with more precise and
timelier results, thus transforming medical
practice. These developments have in turn enabled
personalized treatment through the emergence of
point-of-care (POC) tests and home-based testing
in the form of blood glucose meters for
diabetics, pregnancy tests and cholesterol tests.
6

Today, more than 4,000 different diagnostic tests
have become available, and as more IVD tests
become compatible with POC environments, health
care providers should take advantage of the
benefits of these evolving IVDs for effective
treatment of life-threatening illnesses through
optimization of healthcare delivery. IVDs have
already tremendously impacted cancer diagnosis
and treatment globally by gaining deeper insights
into genetic pathways of the disease enabled by
human genome sequencing. As a result, identifying
faulty genes, personalized risk predictions and
tailored therapies have now become possible. Big
challenges need to be addressed, however, despite
IVDs being at the top of global market
attractiveness index. Due to these factors, the
IVD companies need to look at each countrys
market landscape and IVD requirements, and then
tailor their entries, launch and marketing
strategies to gain a strong foot hold.
7

CONTRIBUTION OF THE STUDY AND FOR WHOM The
intended audience includes all the stakeholders
of the IVD market diagnostic test manufacturing
companies, disposable vendors, reagent suppliers,
start-ups, technology and business incubators,
venture capital firms, hospitals, diagnostic
labs, physician offices and groups, university
research groups and other involved participants.
With its broad scope and in-depth analyses, this
study is a valuable resource to anyone involved
with or interested in the development and
promotion of IVD technologies. Since this study
provides business and technical information of a
timely nature, industry analysts and investors.
The projections, forecasts and trend analyses
found in this report provide readers with the
necessary data and information for careful
decision-making and products that will best meet
the needs of the IVD segment.
8

SCOPE OF REPORT The scope of this study is
global. The report analyzes each market and its
applications, regulatory environment,
technologies involved, market projections and
market shares. The emerging markets discussed
include countries such as India, China, Korea,
Taiwan, Africa, Australia, Brazil and Russia,
among others. The report also examines the IVD
market drivers as well as restraints and
challenges affecting its growth. Further, the
report also highlights the emerging products and
technologies and associated start-ups that are
likely to accelerate the growth of the IVD
industry through their best practices in the
research and development of IVDs. Excluded from
this study are diagnostic testing such as
imaging, veterinary diagnostics and their
associated products.
9

This study will provide information on these
areas -Structure and current market size of the
IVD market as outlined with forecasts through
2020. -Impact of chronic diseases, growing and
aging populations. -Current technology and
product suppliers and key innovations. -A look at
the IVD industry and trends affecting the
market. -Markets by each segment
(immunochemistry, molecular diagnostics, POC
tests, clinical microbiology, hematology and
tissue diagnostics) provide a global overview
showing market data for the U.S., Europe, Asia
and LAAM regions. -Emerging opportunities and
potential investment opportunity areas for
IVD. -Technology patent trends relating to
IVD. -Profiles for more than 20 companies in the
industry with significant contributions and
market shares.
10

METHODOLOGY Information for this report was
derived from a variety of primary and secondary
research sources, including industry analysts,
annual reports and Securities and Exchange
Commission (SEC) reports, the United Network for
Organ Sharing (UNOS), the Organ Procurement and
Transplantation Network (OPTN), the Scientific
Registry of Transplant Recipients (SRTR), the
Center for Medicare and Medicaid Services (CMS),
the National Institutes of Health (NIH), the
Centers for Disease Control (CDC), other
government agencies and journal articles.
Secondary sources include literature searches,
product literature and press releases.
Projections were based on estimates and
information based on historical revenue trends in
subsegments, validations through primary
research, mergers and acquisitions, and market
trends.
11
Table of Contents
1 INTRODUCTION 2 SUMMARY 3 MARKET LANDSCAPE
4 GLOBAL IVD MARKET BY SUBCATEGORIES 5 GLOBAL
IMMUNOCHEMISTRY MARKET 6 GLOBAL POC TESTING
MARKET 7 GLOBAL HEMATOLOGY MARKET 8 GLOBAL
MOLECULAR DIAGNOSTICS MARKET 9 GLOBAL CLINICAL
MICROBIOLOGY MARKET 10 GLOBAL TISSUE DIAGNOSTICS
MARKET
12
To view the full Executive Summary and Table
of Contents, please visit In Vitro Diagnostics
Technologies Industry 2015 Contact Us-
Phone [phone] Email id
info_at_bharatbook.com Website
www.bharatbook.com Our Blog
https//www.bharatbook.com/blog/